Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
British Journal of Haematology
|
June 24, 2017
MUC1-C is a target in lenalidomide resistant multiple myeloma
Li Yin, Ashujit Tagde, Reddy Gali, et al.
Oncoimmunology
|
September 22, 2017
MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer
Audrey Bouillez, Dennis Adeegbe, Caining Jin, et al.
Molecular Cancer Research : MCR
|
September 24, 2016
MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway
Maroof Alam, Audrey Bouillez, Ashujit Tagde, et al.
Oncotarget
|
October 21, 2017
Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma
Ashujit Tagde, Tahireh Markert, Hasan Rajabi, et al.
British Journal of Pharmacology
|
July 22, 2014
Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma
Poonam Sonawane, Hwang Eui Cho, Ashujit Tagde, et al.
Cancer Research
|
February 3, 2016
Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas
Audrey Bouillez, Hasan Rajabi, Sean Pitroda, et al.
Oncotarget
|
June 4, 2016
MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia
Ashujit Tagde, Hasan Rajabi, Dina Stroopinsky, et al.
Scientific Reports
|
August 9, 2017
MUC1-C activates EZH2 expression and function in human cancer cells
Hasan Rajabi, Masayuki Hiraki, Ashujit Tagde, et al.
Blood
|
February 25, 2016
MUC1-C drives MYC in multiple myeloma
Ashujit Tagde, Hasan Rajabi, Audrey Bouillez, et al.
Oncotarget
|
March 2, 2016
Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells
Masanori Hasegawa, Hidekazu Takahashi, Hasan Rajabi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
British Journal of Haematology
|
June 24, 2017
MUC1-C is a target in lenalidomide resistant multiple myeloma
Li Yin, Ashujit Tagde, Reddy Gali, et al.
Oncoimmunology
|
September 22, 2017
MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer
Audrey Bouillez, Dennis Adeegbe, Caining Jin, et al.
Molecular Cancer Research : MCR
|
September 24, 2016
MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway
Maroof Alam, Audrey Bouillez, Ashujit Tagde, et al.
Oncotarget
|
October 21, 2017
Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma
Ashujit Tagde, Tahireh Markert, Hasan Rajabi, et al.
British Journal of Pharmacology
|
July 22, 2014
Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma
Poonam Sonawane, Hwang Eui Cho, Ashujit Tagde, et al.
Cancer Research
|
February 3, 2016
Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas
Audrey Bouillez, Hasan Rajabi, Sean Pitroda, et al.
Oncotarget
|
June 4, 2016
MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia
Ashujit Tagde, Hasan Rajabi, Dina Stroopinsky, et al.
Scientific Reports
|
August 9, 2017
MUC1-C activates EZH2 expression and function in human cancer cells
Hasan Rajabi, Masayuki Hiraki, Ashujit Tagde, et al.
Blood
|
February 25, 2016
MUC1-C drives MYC in multiple myeloma
Ashujit Tagde, Hasan Rajabi, Audrey Bouillez, et al.
Oncotarget
|
March 2, 2016
Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells
Masanori Hasegawa, Hidekazu Takahashi, Hasan Rajabi, et al.
Page
of 2